Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Anne Lie

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Epilepsy Research|May 20, 2015
Treatment non-adherence as a trigger for status epilepticus: An observational, retrospective study based on therapeutic drug monitoringIngrid Anne Lie, Ingvild Hoggen, Christian Samsonsen, et al.
Multiple Sclerosis and Related Disorders|January 26, 2023
Interferon β1a treatment does not influence serum Epstein-Barr virus antibodies in patients with multiple sclerosisIngrid Anne Lie, Brit Ellen Rød, Silje Stokke Kvistad, et al.
European Radiology|January 3, 2022
The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosisIngrid Anne Lie, Emma Kerklingh, Kristin Wesnes, et al.
Neurology|February 17, 2022
Relationship Between White Matter Lesions and Gray Matter Atrophy in Multiple Sclerosis: A Systematic ReviewIngrid Anne Lie, Merlin M Weeda, Rozemarijn M Mattiesing, et al.
Scientific Reports|October 16, 2025
Multimodal predictors of disability progression and processing speed decline in relapsing-remitting multiple sclerosisMax Korbmacher, Ingrid Anne Lie, Kristin Wesnes, et al.
Neuroimage|July 8, 2026
Regional patterns of grey matter volume decline in relapsing-remitting multiple sclerosis relative to healthy ageingMax Korbmacher, Ingrid Anne Lie, Kristin Wesnes, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2025
Accelerated grey matter degeneration in relapsing remitting multiple sclerosisMax Korbmacher, Ingrid Anne Lie, Kristin Wesnes, et al.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
Normative Modelling of Brain Volume for Diagnostic and Prognostic Stratification in Multiple SclerosisMax Korbmacher, Ingrid Anne Lie, Kristin Wesnes, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 23, 2022
The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple SclerosisIngrid Anne Lie, Kristin Wesnes, Silje S Kvistad, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 2022
Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal studyIngrid Anne Lie, Sezgi Kaçar, Kristin Wesnes, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Epilepsy Research|May 20, 2015
Treatment non-adherence as a trigger for status epilepticus: An observational, retrospective study based on therapeutic drug monitoringIngrid Anne Lie, Ingvild Hoggen, Christian Samsonsen, et al.
Multiple Sclerosis and Related Disorders|January 26, 2023
Interferon β1a treatment does not influence serum Epstein-Barr virus antibodies in patients with multiple sclerosisIngrid Anne Lie, Brit Ellen Rød, Silje Stokke Kvistad, et al.
European Radiology|January 3, 2022
The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosisIngrid Anne Lie, Emma Kerklingh, Kristin Wesnes, et al.
Neurology|February 17, 2022
Relationship Between White Matter Lesions and Gray Matter Atrophy in Multiple Sclerosis: A Systematic ReviewIngrid Anne Lie, Merlin M Weeda, Rozemarijn M Mattiesing, et al.
Scientific Reports|October 16, 2025
Multimodal predictors of disability progression and processing speed decline in relapsing-remitting multiple sclerosisMax Korbmacher, Ingrid Anne Lie, Kristin Wesnes, et al.
Neuroimage|July 8, 2026
Regional patterns of grey matter volume decline in relapsing-remitting multiple sclerosis relative to healthy ageingMax Korbmacher, Ingrid Anne Lie, Kristin Wesnes, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2025
Accelerated grey matter degeneration in relapsing remitting multiple sclerosisMax Korbmacher, Ingrid Anne Lie, Kristin Wesnes, et al.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
Normative Modelling of Brain Volume for Diagnostic and Prognostic Stratification in Multiple SclerosisMax Korbmacher, Ingrid Anne Lie, Kristin Wesnes, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 23, 2022
The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple SclerosisIngrid Anne Lie, Kristin Wesnes, Silje S Kvistad, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 2022
Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal studyIngrid Anne Lie, Sezgi Kaçar, Kristin Wesnes, et al.
Pageof 1